Johnson & Johnson (JNJ)
270.72
+0.04
(+0.01%)
USD |
NYSE |
Sep 25, 15:34
Johnson & Johnson Research and Development Expense (Annual) : 14.83B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 14.83B |
| December 31, 2024 | 17.26B |
| December 31, 2023 | 15.05B |
| December 31, 2022 | 14.28B |
| December 31, 2021 | 14.74B |
| December 31, 2020 | 12.02B |
| December 31, 2019 | 11.25B |
| December 31, 2018 | 10.56B |
| December 31, 2017 | 10.43B |
| December 31, 2016 | 9.005B |
| December 31, 2015 | 9.052B |
| December 31, 2014 | 8.501B |
| December 31, 2013 | 8.199B |
| December 31, 2012 | 7.684B |
| December 31, 2011 | 7.526B |
| December 31, 2010 | 6.901B |
| December 31, 2009 | 6.999B |
| December 31, 2008 | 7.577B |
| December 31, 2007 | 7.68B |
| December 31, 2006 | 7.125B |
| December 31, 2005 | 6.312B |
| December 31, 2004 | 5.203B |
| December 31, 2003 | 4.684B |
| Date | Value |
|---|---|
| December 31, 2002 | 3.957B |
| December 31, 2001 | 3.591B |
| December 31, 2000 | 2.926B |
| December 31, 1999 | 2.60B |
| December 31, 1998 | 2.269B |
| December 31, 1997 | 2.14B |
| December 31, 1996 | 1.905B |
| December 31, 1995 | 1.634B |
| December 31, 1994 | 1.278B |
| December 31, 1993 | 1.182B |
| December 31, 1992 | 1.127B |
| December 31, 1991 | 980.00M |
| December 31, 1990 | 834.00M |
| December 31, 1989 | 719.00M |
| December 31, 1988 | 674.00M |
| December 31, 1987 | 617.00M |
| December 31, 1986 | 521.30M |
| December 31, 1985 | 471.10M |
| December 31, 1984 | 421.20M |
| December 31, 1983 | 405.10M |
| December 31, 1982 | 363.20M |
| December 31, 1981 | 282.90M |
| December 31, 1980 | 232.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |
| Pfizer Inc. | 10.25B |
| Bristol Myers Squibb Co. | 9.492B |
| Liquidia Corp. | 38.45M |